Sanuwave Health Return on Tangible Equity 2010-2024 | SNWV

Current and historical return on tangible equity values for Sanuwave Health (SNWV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Sanuwave Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.00B $-0.07B 1.69%
2024-06-30 $-0.00B $-0.05B 6.58%
2024-03-31 $-0.02B $-0.06B 27.17%
2023-12-31 $-0.03B $-0.06B 38.24%
2023-09-30 $-0.05B $-0.08B 74.07%
2023-06-30 $-0.03B $-0.07B 45.57%
2023-03-31 $-0.02B $-0.07B 34.12%
2022-12-31 $-0.01B $-0.05B 20.51%
2022-09-30 $-0.01B $-0.05B 26.80%
2022-06-30 $-0.02B $-0.05B 33.33%
2022-03-31 $-0.03B $-0.05B 58.70%
2021-12-31 $-0.03B $-0.05B 65.85%
2021-09-30 $-0.03B $-0.04B 85.71%
2021-06-30 $-0.04B $-0.04B 121.88%
2021-03-31 $-0.03B $-0.03B 130.77%
2020-12-31 $-0.03B $-0.03B 147.13%
2020-09-30 $-0.02B $-0.03B 133.33%
2020-06-30 $-0.01B $-0.02B 101.96%
2020-03-31 $-0.01B $-0.01B 92.31%
2019-12-31 $-0.01B $-0.01B 80.00%
2019-09-30 $-0.01B $-0.01B 66.67%
2019-06-30 $-0.01B $-0.02B 53.33%
2019-03-31 $-0.01B $-0.02B 54.24%
2018-12-31 $-0.01B $-0.02B 84.21%
2018-09-30 $-0.01B $-0.01B 100.00%
2018-06-30 $-0.01B $-0.02B 108.33%
2018-03-31 $-0.01B $-0.01B 107.32%
2017-12-31 $-0.01B $-0.01B 58.82%
2017-09-30 $-0.00B $-0.01B 51.61%
2017-06-30 $-0.00B $-0.01B 57.14%
2017-03-31 $-0.00B $-0.01B 61.54%
2016-12-31 $-0.01B $-0.01B 96.00%
2016-09-30 $-0.01B $-0.01B 83.33%
2016-06-30 $-0.01B $-0.01B 83.33%
2016-03-31 $-0.01B $-0.01B 104.35%
2015-12-31 $-0.01B $-0.01B 100.00%
2015-09-30 $-0.00B $-0.01B 100.00%
2015-06-30 $-0.00B $-0.01B 145.45%
2015-03-31 $-0.00B $-0.00B 266.67%
2014-12-31 $-0.01B $-0.00B 1200.00%
2014-09-30 $-0.01B $-0.00B 400.00%
2014-06-30 $-0.01B $0.00B 307.69%
2014-03-31 $-0.01B $0.00B 138.46%
2013-12-31 $-0.01B $-0.01B 112.82%
2013-09-30 $-0.01B $-0.01B 120.00%
2013-06-30 $-0.01B $-0.01B 90.00%
2013-03-31 $-0.01B $-0.01B 109.09%
2012-12-31 $-0.01B $-0.01B 92.31%
2012-09-30 $-0.01B $-0.01B 114.29%
2012-06-30 $-0.01B $-0.01B 186.67%
2012-03-31 $-0.01B $-0.01B 444.44%
2011-12-31 $-0.01B $-0.00B 285.71%
2011-09-30 $-0.02B $-0.00B 260.87%
2011-06-30 $-0.02B $0.00B 172.97%
2011-03-31 $-0.02B $-0.01B 120.00%
2010-12-31 $-0.02B $-0.01B 128.00%
2010-09-30 $-0.01B $-0.02B 104.35%
2010-06-30 $-0.01B $-0.01B 129.73%
2010-03-31 $-0.01B $-0.01B 133.33%
2009-12-31 $-0.01B $-0.01B 200.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.231B $0.020B
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $234.047B 28.90
Boston Scientific (BSX) United States $154.056B 41.59
Stryker (SYK) United States $148.022B 31.82
EssilorLuxottica (ESLOY) France $137.298B 0.00
Medtronic (MDT) Ireland $115.624B 16.89
Lonza Group Ag (LZAGY) Switzerland $46.792B 0.00
Haleon (HLN) United Kingdom $45.950B 29.85
GE HealthCare Technologies (GEHC) United States $41.418B 20.17
Agilent Technologies (A) United States $38.594B 25.57
ResMed (RMD) United States $33.728B 25.98
Terumo (TRUMY) Japan $25.984B 36.95
Koninklijke Philips (PHG) Netherlands $24.420B 17.44
Zimmer Biomet Holdings (ZBH) United States $21.098B 13.25
Insulet (PODD) United States $19.908B 85.13
Baxter (BAX) United States $17.948B 12.94
Smith & Nephew SNATS (SNN) United Kingdom $11.490B 0.00
Sunny Optical Technology (SNPTF) China $11.331B 0.00
BellRing Brands (BRBR) United States $9.348B 35.03
Demant (WILYY) Denmark $8.092B 0.00
Bio-Rad Laboratories (BIO) United States $7.847B 27.17
Lantheus Holdings (LNTH) United States $5.489B 12.75
Prestige Consumer Healthcare (PBH) United States $4.215B 20.11
ICU Medical (ICUI) United States $3.924B 37.35
Envista Holdings (NVST) United States $3.683B 29.30
Perrigo (PRGO) Ireland $3.443B 10.14
Haemonetics (HAE) United States $3.312B 15.58
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
GN Store Nord (GNNDY) Denmark $2.850B 19.20
QuidelOrtho (QDEL) United States $2.822B 23.71
LeMaitre Vascular (LMAT) United States $2.294B 55.75
Neogen (NEOG) United States $2.261B 26.05
AtriCure (ATRC) United States $1.916B 0.00
Green Thumb Industries (GTBIF) United States $1.494B 26.06
InMode (INMD) Israel $1.330B 11.12
BioLife Solutions (BLFS) United States $1.193B 0.00
AdaptHealth (AHCO) United States $1.150B 8.22
Maravai LifeSciences Holdings (MRVI) United States $1.013B 0.00
Curaleaf Holdings (CURLF) Canada $0.920B 0.00
CeriBell (CBLL) United States $0.911B 0.00
Phibro Animal Health (PAHC) United States $0.896B 13.74
Evolus (EOLS) United States $0.893B 0.00
Capricor Therapeutics (CAPR) United States $0.657B 0.00
Valneva SE (VALN) France $0.635B 0.00
VAREX IMAGING (VREX) United States $0.538B 23.32
Omeros (OMER) United States $0.503B 0.00
Surmodics (SRDX) United States $0.501B 0.00
Owens & Minor (OMI) United States $0.493B 3.85
SNDL (SNDL) Canada $0.439B 0.00
Cresco Labs (CRLBF) United States $0.432B 0.00
ZimVie (ZIMV) United States $0.368B 30.98
SEMPERIT AG HLD (SEIGY) Austria $0.349B 0.00
Verano Holdings (VRNOF) United States $0.349B 0.00
Quanterix (QTRX) United States $0.311B 0.00
Sanara MedTech (SMTI) United States $0.309B 0.00
Aurora Cannabis (ACB) Canada $0.308B 56.10
Cerus (CERS) United States $0.305B 0.00
Viemed Healthcare (VMD) United States $0.300B 28.52
OraSure Technologies (OSUR) United States $0.298B 19.95
Biote (BTMD) United States $0.252B 5.52
Canopy Growth (CGC) Canada $0.252B 0.00
Zynex (ZYXI) United States $0.234B 49.07
High Tide (HITI) Canada $0.205B 0.00
Utah Medical Products (UTMD) United States $0.204B 15.21
Brainsway (BWAY) Israel $0.184B 97.80
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
MacroGenics (MGNX) United States $0.166B 0.00
TerrAscend (TSNDF) Canada $0.164B 0.00
Organigram Holdings (OGI) Canada $0.154B 0.00
FitLife Brands (FTLF) United States $0.137B 17.17
Jin Medical (ZJYL) China $0.114B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
Fonar (FONR) United States $0.092B 12.92
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.083B 0.00
InterCure (INCR) Israel $0.076B 0.00
Jushi Holdings (JUSHF) United States $0.069B 0.00
Exagen (XGN) United States $0.063B 0.00
Cytosorbents (CTSO) United States $0.060B 0.00
Rockwell Medical (RMTI) United States $0.057B 29.17
Apyx Medical (APYX) United States $0.054B 0.00
Hongchang (HCIL) China $0.051B 0.00
United-Guardian (UG) United States $0.046B 13.24
ImmuCell (ICCC) United States $0.045B 0.00
Modular Medical (MODD) United States $0.042B 0.00
INLIF (INLF) $0.032B 0.00
Safety Shot (SHOT) United States $0.028B 0.00
Nephros (NEPH) United States $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
Allurion Technologies (ALUR) United States $0.009B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00